Project SOLO CONTINUE – R668-AD-1415

Basic data

Acronym:
SOLO CONTINUE
Title:
R668-AD-1415
Duration:
01/08/2015 to 31/01/2016
Abstract / short description:
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE EFFICACY AND SAFETY OF MULTIPLE DUPILUMAB DOSE REGIMENS ADMINISTERED AS MONOTHERAPY FOR MAINTAINING TREATMENT RESPONSE IN PATIENTS WITH ATOPIC DERMATITIS
Keywords:
skin diseases
Hautkrankheiten
antibodies
Antikörper

Involved staff

Managers

Faculty of Medicine
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Tarrytown, New York, United States of America
Help

will be deleted permanently. This cannot be undone.